| First Author | Vermehren-Schmaedick A | Year | 2021 |
| Journal | Cells | Volume | 10 |
| Issue | 6 | PubMed ID | 34067418 |
| Mgi Jnum | J:319836 | Mgi Id | MGI:6814822 |
| Doi | 10.3390/cells10061289 | Citation | Vermehren-Schmaedick A, et al. (2021) Characterization of PARP6 Function in Knockout Mice and Patients with Developmental Delay. Cells 10(6) |
| abstractText | PARP6, a member of a family of enzymes (17 in humans) known as poly-ADP-ribose polymerases (PARPs), is a neuronally enriched PARP. While previous studies from our group show that Parp6 is a regulator of dendrite morphogenesis in rat hippocampal neurons, its function in the nervous system in vivo is poorly understood. Here, we describe the generation of a Parp6 loss-of-function mouse model for examining the function of Parp6 during neurodevelopment in vivo. Using CRISPR-Cas9 mutagenesis, we generated a mouse line that expressed a Parp6 truncated variant (Parp6(TR)) in place of Parp6(WT). Unlike Parp6(WT), Parp6(TR) is devoid of catalytic activity. Homozygous Parp6(TR) do not exhibit obvious neuromorphological defects during development, but nevertheless die perinatally. This suggests that Parp6 catalytic activity is important for postnatal survival. We also report PARP6 mutations in six patients with several neurodevelopmental disorders, including microencephaly, intellectual disabilities, and epilepsy. The most severe mutation in PARP6 (C563R) results in the loss of catalytic activity. Expression of Parp6(C563R) in hippocampal neurons decreases dendrite morphogenesis. To gain further insight into PARP6 function in neurons we also performed a BioID proximity labeling experiment in hippocampal neurons and identified several microtubule-binding proteins (e.g., MAP-2) using proteomics. Taken together, our results suggest that PARP6 is an essential microtubule-regulatory gene in mice, and that the loss of PARP6 catalytic activity has detrimental effects on neuronal function in humans. |
